echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The State Food and Drug Administration held a key laboratory work exchange and promotion meeting

    The State Food and Drug Administration held a key laboratory work exchange and promotion meeting

    • Last Update: 2021-07-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     On March 5, the State Food and Drug Administration held a key laboratory work exchange and promotion meeting to analyze the situation, exchange experience, clarify tasks, and promote the work of key laboratories to a new level
    .
    Xu Jinghe, member of the Party Leadership Group and Deputy Director of the State Food and Drug Administration, attended the meeting and delivered a speech

    .


      

      Xu Jinghe pointed out that doing a good job in the construction of key laboratories is the need to accelerate the leap from a major pharmaceutical country to a strong pharmaceutical country, to accelerate the modernization of the drug regulatory system and regulatory capabilities, and to accelerate the implementation of China's drug regulatory scientific action plan.
    It is the need to accelerate the high-quality development of drug regulatory undertakings.
    It is necessary to deeply understand the significance of the construction of key laboratories and accelerate the construction of key pharmaceutical laboratories

    .

      

      At the meeting, representatives of 5 laboratories gave speeches
    .
    The Key Laboratory for Quality Research and Evaluation of Biological Products is built by the Institute of Biological Products Control, China Food and Drug Control Institute, and is one of the first batch of key laboratories of the State Food and Drug Administration

    .
    In the past year, the laboratory has newly built a number of vaccines, immunotherapy and stem cell preparation testing technologies and methods to prepare sufficient technical reserves for the fight against the new crown pneumonia epidemic

    .
    In the near future, it is planned to prepare to apply for a national key laboratory

    .

      

      The Key Laboratory of Biomaterial Safety Evaluation was jointly declared by the Shandong Medical Device Inspection Center and the Biomaterials Joint Testing Center of Sichuan University.
    It is one of the first batch of key laboratories

    .
    By undertaking research projects related to the China Pharmaceutical Regulatory Scientific Action Plan, we have achieved a breakthrough in China's new biodegradable biomaterial device supervision technology system from scratch, and solved the technical problem of safety supervision of new biodegradable biomaterial devices

    .

      

      The key laboratory of cosmetics monitoring and evaluation relies on the construction of Shanghai Food and Drug Inspection and Research Institute
    .
    In the past year, it has fully participated in the formulation and revision of 19 cosmetic standards, undertook 16 cosmetic risk monitoring tasks, participated in safety risk assessment, and explored the establishment of a database of certain raw material risk substances, which has become an important force in the construction of cosmetics technical support system

    .

      

      The Key Laboratory of Generic Drug Research and Evaluation is composed of Beijing Institute of Drug Control, National Pharmacopoeia Commission, and Institute of Materia Medica, Chinese Academy of Medical Sciences
    .
    Over the past year, we have carried out a total of 81 subject researches on generic drugs, assisted the selection of reference preparations, and actively provided companies with consistency evaluation technical services, forming a joint development of generic drugs from prescription process development, in vivo and in vitro evaluation to supervision and industrial applications

    .

      

      Relying on the construction of Beijing University of Traditional Chinese Medicine, the Key Laboratory of Chinese Medicine Research and Evaluation is one of the second batch of newly established key laboratories
    .
    The laboratory aims to build a new TCM drug review system that meets the characteristics of TCM, build a TCM toxicity research platform, build a post-marketing clinical re-evaluation research mechanism platform, and make every effort to improve the scientific, standardized, and international level of TCM

    .

      

      In recent years, provincial drug regulatory authorities have actively participated in the construction of key laboratories of the State Food and Drug Administration, and have achieved remarkable results in several aspects
    .
    According to the Guangdong Provincial Drug Administration, the province has always focused its key laboratories on promoting scientific and technological innovation and developing regulatory science, forming a good atmosphere for scientific and technological innovation and scientific research cooperation

    .
    At present, a total of 17 key laboratories of the State Food and Drug Administration have settled in Guangdong, ranking first in the country in number, providing a strong impetus for the development of Guangdong's pharmaceutical industry

    .

      

      Xu Jinghe fully affirmed the work effect of the key laboratory and put forward two requirements for the next key laboratory construction
    .
    The first is that key laboratories must conscientiously do the "two services" and continue to improve their own capabilities

    .
    First, we must persist in serving the innovation of the pharmaceutical industry, and in accordance with the requirements of General Secretary Xi Jinping’s "four aspects", while increasing basic research and applied research, actively participate in and vigorously support the innovation of pharmaceutical companies and develop more innovative products; Persist in serving the needs of drug regulatory work, actively participate in regulatory scientific research, and innovate a number of regulatory tools, standards, and methods to help accelerate product launches and improve regulatory quality

    .
    The second is that the supervisory department must do a good job in service and management, and promote the efficient operation of the system

    .
    It is necessary to scientifically plan the construction layout of key laboratories, and clarify the development direction and tasks

    .
    It is necessary to strengthen management evaluation, actively support the operation and development of key laboratories, and establish a dynamic adjustment mechanism to carry out supervision and inspection and dynamic evaluation in a timely manner

    .

      

      The meeting was held in a combination of online and offline methods.
    The relevant persons in charge of the relevant business departments of the State Food and Drug Administration, personnel from the key laboratory construction and management office of the State Food and Drug Administration attended the main venue, and the relevant persons in charge of the relevant provincial drug regulatory authorities , The directors of the first and second batches of key laboratories and the main persons in charge of the supporting units attended the conference at each branch venue

    .


    Source: official website of the State Drug Administration

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.